<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01808846</url>
  </required_header>
  <id_info>
    <org_study_id>1001006251</org_study_id>
    <secondary_id>R01DK085577</secondary_id>
    <nct_id>NCT01808846</nct_id>
  </id_info>
  <brief_title>Neural Functioning of Feeding Centers in Obese Youth</brief_title>
  <official_title>Neural Functioning of Feeding Centers in Obese Youth</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore whether obese adolescents with insulin resistance and relative low leptin levels&#xD;
      exhibit functional alterations of the neuronal circuits involved in the regulation of energy&#xD;
      metabolism and food seeking behaviors.&#xD;
&#xD;
      We here propose to test the hypothesis that the reward circuitry is dysregulated in obese&#xD;
      adolescents and is related to the degree of insulin resistance and hyperinsulinemia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Functional Magnetic Resonance Imaging (fMRI) provides a non-invasive method to assess the&#xD;
      functional pathways affected by nutrient ingestion and therefore can help answer important&#xD;
      questions regarding potential differences in the response of brain regions involved in&#xD;
      feeding.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2010</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>measure of cerebral blood flow response to glucose ingestion</measure>
    <time_frame>Baseline and 2 year follow up</time_frame>
    <description>fmri on 3T to measure blood flow response after ingestion of glucose drink</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>measure of cerebral blood flow response to fructose ingestion</measure>
    <time_frame>Baseline and 2 year follow up</time_frame>
    <description>fmri on 3T to measure blood flow response after ingestion of fructose drink</description>
  </secondary_outcome>
  <other_outcome>
    <measure>measure of BOLD signal brain reactivity to food cues</measure>
    <time_frame>Baseline and 2 year follow up</time_frame>
    <description>fmri on 3T to measure blood flow response to visually presented food cues</description>
  </other_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">51</enrollment>
  <condition>Obesity</condition>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>Lean Adolescents</arm_group_label>
    <description>Kids aged 12-17 with body mass index less than 25% and normal glucose tolerance test results</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese Insulin Sensitive</arm_group_label>
    <description>Obese Insulin Sensitive Adolescents aged 12-17 with BMI&gt;95th% and whole body insulin sensitivity index &gt; 3.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese Insulin Resistant Adolscent</arm_group_label>
    <description>Obese Insulin Resistant Adolescents 12-17 with BMI&gt; 95th% and WBISI&lt;1.2.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Clinic patients of Dr. Caprio at the Yale Pediatric Obesity Clinic who have undergone oral&#xD;
        glucose tolerance testing (OGTT) and found to be insulin resistant or sensitive and/or&#xD;
        previous research subjects who were found to be insulin resistant or sensitive and who&#xD;
        agreed to be contacted for other studies will be contacted.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Obese adolescents&#xD;
&#xD;
          -  Good general health,&#xD;
&#xD;
          -  taking no medication on a chronic basis&#xD;
&#xD;
          -  Age 12 to 17 yrs,&#xD;
&#xD;
          -  in puberty (girls and boys: Tanner stage II - IV)&#xD;
&#xD;
        Obese Insulin Resistant Adolescents&#xD;
&#xD;
          -  (BMI&gt; 95th)&#xD;
&#xD;
          -  (WBISI&lt;1.2 plus a low adiponectin &lt;6 ug/dl and&#xD;
&#xD;
          -  high triglyceride levels &gt;130mg/dl)&#xD;
&#xD;
        Obese Insulin Sensitive Adolescents&#xD;
&#xD;
          -  (BMI&gt;95th)&#xD;
&#xD;
          -  (WBISI &gt;3) plus high adiponectin &gt;8 ug/ml and&#xD;
&#xD;
          -  triglyceride levels &gt; 80 mg/dl Girls who begin menstruating must have a negative&#xD;
             pregnancy test during the study&#xD;
&#xD;
        Eligibility criteria for healthy non-obese children and adolescents:&#xD;
&#xD;
          -  Brother or sister with obesity&#xD;
&#xD;
          -  Age 12 to 17 years&#xD;
&#xD;
          -  Normal fasting glucose and lipids in the child, and&#xD;
&#xD;
          -  normal OGTT&#xD;
&#xD;
          -  No use of any medication known to affect glucose, lipid metabolism and inflammation&#xD;
&#xD;
          -  No endocrinopathies&#xD;
&#xD;
          -  No use of any antipsychotic medication&#xD;
&#xD;
          -  BMI &gt;25th to &lt;75th ( Center for Disease Control (CDC) BMI Charts)&#xD;
&#xD;
          -  Minimum weight of 90lbs (CDC Growth Charts)&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Baseline creatinine &gt;1.0 mg&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Presence of endocrinopathies (e.g. Cushing syndrome)&#xD;
&#xD;
          -  Cardiac or pulmonary or other significant chronic illness&#xD;
&#xD;
          -  Adolescents with psychiatric disorder or with substance abuse determined via&#xD;
             self-report.&#xD;
&#xD;
          -  Use of anorexic agents No metal implants&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sonia Caprio, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <study_first_submitted>October 30, 2012</study_first_submitted>
  <study_first_submitted_qc>March 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2013</study_first_posted>
  <last_update_submitted>April 25, 2017</last_update_submitted>
  <last_update_submitted_qc>April 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yale University</investigator_affiliation>
    <investigator_full_name>Sonia Caprio</investigator_full_name>
    <investigator_title>Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Insulin Resistance</keyword>
  <keyword>functional magnetic resonance imaging</keyword>
  <keyword>glucose</keyword>
  <keyword>fructose</keyword>
  <keyword>hypothalamus</keyword>
  <keyword>neuronal circuits</keyword>
  <keyword>feeding behavior</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

